These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 9873820)
1. Telomerase is strongly activated in hepatocellular carcinoma but not in chronic hepatitis and cirrhosis. Park YM; Choi JY; Byun BH; Cho CH; Kim HS; Kim BS Exp Mol Med; 1998 Mar; 30(1):35-40. PubMed ID: 9873820 [TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis and in situ localization of human telomerase RNA in chronic liver disease and hepatocellular carcinoma. Ogami M; Ikura Y; Nishiguchi S; Kuroki T; Ueda M; Sakurai M Lab Invest; 1999 Jan; 79(1):15-26. PubMed ID: 9952107 [TBL] [Abstract][Full Text] [Related]
3. Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma. Nouso K; Urabe Y; Higashi T; Nakatsukasa H; Hino N; Ashida K; Kinugasa N; Yoshida K; Uematsu S; Tsuji T Cancer; 1996 Jul; 78(2):232-36. PubMed ID: 8673997 [TBL] [Abstract][Full Text] [Related]
4. Telomerase activity in hepatocellular carcinoma and adjacent liver tissues. Kishimoto K; Fujimoto J; Takeuchi M; Yamamoto H; Ueki T; Okamoto E J Surg Oncol; 1998 Nov; 69(3):119-24. PubMed ID: 9846496 [TBL] [Abstract][Full Text] [Related]
5. In situ detection of telomerase enzymatic activity in human hepatocellular carcinogenesis. Youssef N; Paradis V; Ferlicot S; Bedossa P J Pathol; 2001 Aug; 194(4):459-65. PubMed ID: 11523054 [TBL] [Abstract][Full Text] [Related]
7. [Study on telomerase activity in hepatocellular carcinoma and chronic hepatitic disease]. Wu S; Liew CT; Li X Zhonghua Bing Li Xue Za Zhi; 1998 Apr; 27(2):91-3. PubMed ID: 11244969 [TBL] [Abstract][Full Text] [Related]
8. Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis. Satra M; Gatselis N; Iliopoulos D; Zacharoulis D; Dalekos GN; Tsezou A J Viral Hepat; 2007 Jan; 14(1):41-7. PubMed ID: 17212643 [TBL] [Abstract][Full Text] [Related]
9. Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis. Miura N; Horikawa I; Nishimoto A; Ohmura H; Ito H; Hirohashi S; Shay JW; Oshimura M Cancer Genet Cytogenet; 1997 Jan; 93(1):56-62. PubMed ID: 9062581 [TBL] [Abstract][Full Text] [Related]
10. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status. Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485 [TBL] [Abstract][Full Text] [Related]
11. Precancerous hepatic nodules had significant levels of telomerase activity determined by sensitive quantitation using a hybridization protection assay. Takaishi H; Kitamoto M; Takahashi S; Aikata H; Kawakami Y; Nakanishi T; Nakamura Y; Shimamoto F; Kajiyama G; Ide T Cancer; 2000 Jan; 88(2):312-7. PubMed ID: 10640962 [TBL] [Abstract][Full Text] [Related]
12. Telomerase activity and telomerase catalytic subunit in hepatocellular carcinoma. Lee CM; Hsu CY; Eng HL; Huang WS; Lu SN; Changchien CS; Chen CL; Cho CL Hepatogastroenterology; 2004; 51(57):796-800. PubMed ID: 15143919 [TBL] [Abstract][Full Text] [Related]
13. Clinical significance of telomerase activity in hepatocellular carcinoma. Ohta K; Kanamaru T; Yamamoto M; Saitoh Y Kobe J Med Sci; 1996 Jun; 42(3):207-17. PubMed ID: 8973088 [TBL] [Abstract][Full Text] [Related]
14. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Tahara H; Nakanishi T; Kitamoto M; Nakashio R; Shay JW; Tahara E; Kajiyama G; Ide T Cancer Res; 1995 Jul; 55(13):2734-6. PubMed ID: 7796395 [TBL] [Abstract][Full Text] [Related]
15. Dynamic alteration of telomerase expression and its diagnostic significance in liver or peripheral blood for hepatocellular carcinoma. Yao DF; Wu W; Yao M; Qiu LW; Wu XH; Su XQ; Zou L; Yao DB; Meng XY World J Gastroenterol; 2006 Aug; 12(31):4966-72. PubMed ID: 16937491 [TBL] [Abstract][Full Text] [Related]
16. Profiles of carbohydrate-metabolizing enzymes in human hepatocellular carcinomas and preneoplastic livers. Taketa K; Shimamura J; Ueda M; Shimada Y; Kosaka K Cancer Res; 1988 Jan; 48(2):467-74. PubMed ID: 2825976 [TBL] [Abstract][Full Text] [Related]
17. Human hepatocellular carcinoma and putative precancerous disorders: their enzyme histochemical study. Uchida T; Miyata H; Shikata T Arch Pathol Lab Med; 1981 Apr; 105(4):180-6. PubMed ID: 6111303 [TBL] [Abstract][Full Text] [Related]
18. Quantitative evaluation of telomerase activity in small liver tumors: analysis of ultrasonography-guided liver biopsy specimens. Kojima H; Yokosuka O; Kato N; Shiina S; Imazeki F; Saisho H; Shiratori Y; Omata M J Hepatol; 1999 Sep; 31(3):514-20. PubMed ID: 10488712 [TBL] [Abstract][Full Text] [Related]
19. Abnormal expression of hepatomas and circulating telomerase and its clinical values. Wu W; Yao DF; Qiu LW; Wu XH; Yao M; Su XQ; Zou L Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):544-9. PubMed ID: 16286259 [TBL] [Abstract][Full Text] [Related]
20. Immuno-histochemical detection of human telomerase reverse transcriptase in human liver tissues. Kawakami Y; Kitamoto M; Nakanishi T; Yasui W; Tahara E; Nakayama J; Ishikawa F; Tahara H; Ide T; Kajiyama G Oncogene; 2000 Aug; 19(34):3888-93. PubMed ID: 10951582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]